BioNTech SE Adjustments For Unrealised Foreign Exchange Losses Gains
BioNTech SE (BNTX) reported Adjustments For Unrealised Foreign Exchange Losses Gains of -EUR 6.60 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Income Statement › Other Income
ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains · last filed 2026-03-10
| Period end | Adjustments For Unrealised Foreign Exchange Losses Gains 12 month | Adjustments For Unrealised Foreign Exchange Losses Gains 12 month as first filed |
|---|---|---|
| 2025-12-31 | -6.60M EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | -109.50M EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | -298.00M EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 625.50M EUR 20-F · filed 2025-03-10 | |
| 2021-12-31 | -387.50M EUR 20-F · filed 2024-03-20 | |
| 2020-12-31 | 41.30M EUR 20-F · filed 2023-03-27 | 41.27M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 100.00K EUR 20-F/A · filed 2022-10-26 | 70.00K EUR 20-F · filed 2020-03-31 |
| 2018-12-31 | 459.00K EUR 20-F · filed 2021-03-30 | |
| 2017-12-31 | 24.82M EUR 20-F · filed 2020-03-31 |